What is the differential diagnosis for a patient with acute renal failure, a diffuse petechial rash involving the palms and soles, and a prolonged INR while on coumadin (warfarin)?

Differential Diagnosis: Acute Renal Failure, Petechial Rash (Palms/Soles), and Prolonged INR on Warfarin

The most critical diagnosis to consider immediately is Rocky Mountain Spotted Fever (RMSF), followed by warfarin-related nephropathy with excessive anticoagulation causing bleeding manifestations, and drug-induced acute interstitial nephritis with hypersensitivity reaction.

Primary Life-Threatening Considerations

Rocky Mountain Spotted Fever (RMSF)

• Classic presentation includes petechial rash involving palms and soles, acute renal failure, and thrombocytopenia 1
• The petechial rash typically appears by day 5-6 of illness and indicates advanced disease with systemic vasculitis 1
• RMSF causes acute kidney injury through systemic vasculitis affecting vascular endothelium, leading to increased capillary permeability, microhemorrhage, and platelet consumption 1
• Thrombocytopenia is a common laboratory finding and can contribute to coagulopathy 1
• Case-fatality rate is 5-10% overall, but increases to 40-50% when treatment is delayed beyond day 8 of illness 1
• The classic triad of fever, rash, and tick bite is present in only a minority of patients at initial presentation 1

Warfarin-Related Nephropathy (WRN)

• WRN occurs when INR exceeds 3.0 and manifests as acute kidney injury from glomerular hemorrhage with red blood cell casts obstructing renal tubules 2, 3, 4
• This patient's prolonged INR on warfarin makes WRN a critical consideration 2, 3
• WRN occurs in 20.5% of patients with INR >3, with higher rates (33%) in those with pre-existing chronic kidney disease 2
• Patients with CKD are twice as likely to develop anticoagulant-related nephropathy compared to those without underlying renal disease 5
• The 1-year mortality with WRN is 31.1% compared to 18.9% without WRN, representing a 65% increased risk of death 2
• Petechiae and bleeding manifestations occur due to excessive anticoagulation 6

Drug-Induced Acute Interstitial Nephritis (DI-AIN)

• DI-AIN presents with acute renal failure and may include maculopapular rash as part of a type IV delayed hypersensitivity reaction 7, 8
• The classic triad of fever, rash, and eosinophilia is present in only a minority of cases 8
• Antibiotics, NSAIDs, and proton pump inhibitors are the most common causative agents 8
• Eosinophiluria may be present and supports this diagnosis 7
• Warfarin itself can interact with multiple medications that may precipitate DI-AIN 9

Secondary Considerations

Thrombotic Thrombocytopenic Purpura (TTP)

• RMSF-associated neurologic manifestations, renal failure, and thrombocytopenia can mimic TTP 1
• TTP classically presents with microangiopathic hemolytic anemia, thrombocytopenia, renal failure, fever, and neurologic changes
• Petechial rash can occur due to severe thrombocytopenia

Meningococcemia

• RMSF-associated cutaneous necrosis and petechial rash can be confused with purpura fulminans from meningococcemia 1
• Presents with acute onset fever, petechial/purpuric rash, and can cause acute renal failure from septic shock
• DIC commonly occurs, which could explain prolonged INR

Ehrlichiosis

• Ehrlichia chaffeensis causes rash in approximately 30% of adults and 60% of children, with variable patterns that may involve palms and soles 1
• Common laboratory findings include leukopenia, thrombocytopenia, increased hepatic transaminases, and hyponatremia 1
• Case-fatality rate is approximately 3% 1

Critical Diagnostic Approach

Immediate Laboratory Evaluation

• Check INR level urgently—if INR >3.0, consider WRN; if INR >10, risk of severe complications increases dramatically 2, 3, 10
• Complete blood count with differential (look for thrombocytopenia, eosinophilia, leukopenia) 1
• Urinalysis for hematuria, red blood cell casts (WRN), eosinophiluria (DI-AIN) 2, 3, 7
• Serum creatinine and compare to baseline 2, 4
• Peripheral blood smear for schistocytes (TTP, DIC)
• Hepatic transaminases and sodium levels (RMSF, ehrlichiosis) 1

Specific Testing Based on Clinical Context

• For suspected RMSF: immunohistochemical staining or PCR testing, though treatment should NOT be delayed for confirmatory testing 1
• For suspected WRN: assess for hematuria and obtain renal biopsy if diagnosis unclear and patient stable enough 2, 3, 4
• For suspected DI-AIN: review all medications, check urine eosinophils, consider renal biopsy 7, 8
• Blood cultures if sepsis/meningococcemia suspected

Management Priorities

If RMSF Suspected

• Initiate doxycycline immediately without waiting for confirmatory testing—delay beyond day 5 of illness significantly increases mortality 1

If WRN Confirmed with Supratherapeutic INR

• Discontinue warfarin immediately 6
• Administer vitamin K (oral or parenteral) based on INR level and bleeding severity 6, 3
• For life-threatening bleeding: consider prothrombin complex concentrate (PCC), fresh frozen plasma, or activated Factor VII, though these carry thrombosis risk 6
• Monitor renal function closely as recovery may be incomplete 2, 3, 4

If DI-AIN Suspected

• Withdraw all potentially causative medications immediately 7, 8
• Consider corticosteroids if no improvement in renal function after 5-7 days of drug withdrawal 8, 4

Critical Pitfalls to Avoid

• Do not wait for the classic triad of fever, rash, and tick bite before treating suspected RMSF—this triad is present in only a minority of cases 1
• Do not assume normal renal function excludes WRN—it occurs in patients with and without pre-existing CKD 2
• Patients with CKD on warfarin have more labile INRs and increased risk of supratherapeutic levels, especially during initiation 5
• Peak INR after warfarin overdose occurs 24-36 hours after presentation, so serial monitoring is essential 10
• The absence of rash does not exclude RMSF—less than 50% have rash in first 3 days, and some never develop rash 1